The city of Madison, Wisconsin, currently has 8 active clinical trials seeking participants for Healthy research studies.
A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of PC14586 in Healthy Participants
Recruiting
The purpose of this study is to assess the effect of PC14586 pharmacokinetics when co administered with itraconazole in healthy participants.
Gender:
All
Ages:
Between 18 years and 55 years
Trial Updated:
04/08/2024
Locations: Fortrea, Madison, Wisconsin
Conditions: Healthy Volunteers
A First-In-Human Study of LY3839840 in Healthy Participants
Recruiting
The main purpose of this first-in-human study to investigate the safety of LY3839840 in single and multiple doses, and how it's processed in the body when given in different amounts.
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/22/2024
Locations: Fortrea Clinical Research Unit, Madison, Wisconsin
Conditions: Healthy
Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Recruiting
The purpose of this research is assess imaging and identification of soft plaque that undergoes large deformations or strain will identify plaque vulnerable to rupture which could lead to 'silent strokes'. Validation of current study results with MRI will foster use of real-time ultrasound (US) strain imaging and strain indices as a screening tool for identifying normal human participants susceptible to increased vascular aging and developing plaque prone to rupture or micro-embolization. Curre... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
03/19/2024
Locations: Department of Medical Physics, University of Wisconsin, Madison, Wisconsin
Conditions: Healthy, Carotid Artery Diseases
A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-BMS-986368 in Healthy Male Participants
Recruiting
The purpose of this study is to investigate the pharmacokinetics (PK), metabolites, route of elimination, and mass balance of BMS-986368 in healthy male participants.
Gender:
Male
Ages:
Between 18 years and 55 years
Trial Updated:
03/01/2024
Locations: Labcorp Clinical Research Unit - Madison, Madison, Wisconsin
Conditions: Healthy Volunteers
Fully Automated High-Throughput Quantitative MRI of the Liver
Recruiting
The purpose of this research is to see if a new automated magnetic resonance imaging (MRI) method will be able to improve the images taken of the liver. Participants will have either known or suspected liver disease, known or suspected iron overload syndrome, or be a healthy adult. Participants will be in the research study for one day.
Gender:
All
Ages:
7 years and above
Trial Updated:
02/09/2024
Locations: University of Wisconsin, Madison, Wisconsin
Conditions: Healthy, Iron Overload, Liver Fat
A Study to Evaluate the Pharmacokinetics, Safety and Immunogenicity of BIIB800 Subcutaneously (SC) Compared to Actemra® in Healthy Male Participants
Recruiting
The primary objective of the study is to show equivalence in pharmacokinetics (PK) of BIIB800 and Actemra following SC administration of a single dose to healthy male participants. The secondary objective of the study is to evaluate PK over time, clinical safety, pharmacodynamic (PD) profiles and immunogenicity of BIIB800 and Actemra.
Gender:
Male
Ages:
Between 18 years and 55 years
Trial Updated:
02/08/2024
Locations: Fortrea Clinical Research Unit Inc., Madison, Wisconsin
Conditions: Healthy Volunteer
The Role of Cerebellum in Speech
Recruiting
This study will investigate the how the cerebellum is involved in speech motor learning over time and short-term corrections in patients with cerebellar ataxia and healthy controls. This will be accomplished through three approaches: behavioral studies, magnetic resonance imaging (MRI), and transcranial magnetic stimulation (TMS). During behavioral studies, participants will be asked to speak into a microphone while their voice is played back over earphones, and to do other speaking tasks. MRI w... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
11/30/2023
Locations: University of Wisconsin--Madison, Madison, Wisconsin
Conditions: Cerebellar Ataxia, Dysarthria, Healthy
A Study to Evaluate the Drug Levels, Physical and Chemical Changes, and Removal of BMS-986196 in Healthy Male Participants
Recruiting
The purpose of this study is to evaluate the excretion pathway of orally administered [14C]-BMS-986196 and to assess the safety and tolerability of orally administered BMS-986196.
Gender:
Male
Ages:
Between 18 years and 55 years
Trial Updated:
10/16/2023
Locations: Covance Clinical Research Unit - Madison, Madison, Wisconsin +1 locations
Conditions: Healthy Male Volunteers